Top Analyst Upgrades and Downgrades: Amgen, Chipotle, Lam Research, Netgear, Teva Pharmaceutical, Western Digital and More
The futures traded up big Monday morning as we start the final quarter of 2018. With some of the distractions starting to move out of the way, and the Federal Reserve rate increase on the books, Wall Street will be looking forward to the start of the third-quarter earnings reporting season. Add in Canada agreeing to a new trade deal, and stocks look ready to take off.
Many investors have had to deal with seeing lower upside from buying on market pullbacks than in prior years. Now the investing community has to consider how to position their investments for the rest of 2018 and into 2019.
24/7 Wall St. reviews dozens of analyst research reports each day of the week to find new ideas for investors and traders alike. Some analyst reports cover stocks to buy, but some of them cover stocks to sell or to avoid.
Additional commentary has been added on most of the daily analyst reports, along with trading history. The consensus analyst price targets and other valuation metrics are from the Thomson Reuters sell-side research service.
These are the top analyst upgrades, downgrades and initiations seen on Monday, October 1, 2018.
Amgen Inc. (NASDAQ: AMGN) was started with a Neutral rating at Cantor Fitzgerald, which put a $223 price target on the biotech giant. That compares with a Wall Street consensus price target of $204.05. The shares closed trading on Friday at $207.29.
Ciena Corp. (NASDAQ: CIEN) was downgraded to Market Perform from Outperform at Northland Capital. The 52-week trading range for the stock is $19.40 to $32.33. The consensus price target is $34.16, and the stock closed trading on Friday at $31.24.
Chipotle Mexican Grill Inc. (NYSE: CMG) was downgraded to Underperform from Perform at Oppenheimer. The 52-week trading range is $247.52 to $530.58, and the consensus price target is $471.70. The shares closed Friday at $454.52.
Delphi Technologies PLC (NYSE: DLPH) was downgraded to Underperform from Neutral at Merrill Lynch. The 52-week trading range for the car parts behemoth is an incredible $31.35 to $102.99, and the consensus price objective is $51.62. The shares closed trading on Friday at $31.36.
Lam Research Inc. (NASDAQ: LRCX) was downgraded to Neutral from Buy at Mizuho. The 52-week trading range for the semiconductor capital equipment leader is $147.54 to $234.58, and the consensus price target is $230.68. The stock closed way below that level on Friday at $151.70.
LogMein Inc. (NASDAQ: LOGM) is raised to Outperform from Perform at Oppenheimer. The 52-week trading range is $77.05 to $134.80, and the consensus price target is $111.33. The stock ended trading on Friday at $89.10.
Netgear Inc. (NASDAQ: NTGR) was started with a Market Perform rating and a $63 price target at Cowen. That compares to a consensus price target of $85.67. The shares closed trading on Friday at $62.85.
Teva Pharmaceutical Inc. (NASDAQ: TEVA) was added to the Conviction Buy List at Goldman Sachs The 52-week trading range for generic drug giant is $10.85 to $25.96. The consensus price objective is $21.00, but shares closed above that level Friday at $21.54.
Follow @Jonogg on Twitter to receive the daily analyst calls and other market research calls directly on your feed.